Top 20 Optionholders and Distribution List
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The report includes an analysis of holdings as of a specific date, showing the distribution of options among various holders. Percheron is focused on developing novel therapies for oncology, with its lead program currently in clinical trials.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Application for quotation of securities - PER
- Notification regarding unquoted securities - PER
- Update - Proposed issue of securities - PER
- Prospectus - Placement options and JLM options
- FDA Clearance for Vanderbilt Health Clinical Trial in AML
Later from Percheron Therapeutics
All Percheron Therapeutics news releasesFollow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics